Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
- Kanis JA Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.Pontefract@shef.ac.uk.
- Cooper C MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
- Rizzoli R Service of Bone Diseases, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
- Reginster JY Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
- 2018-06-06
Published in:
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. - 2018
Bone mineral density
FRAX
Fracture risk
Intervention thresholds
Treatment guidelines
Bone Density
Bone Density Conservation Agents
Calcium-Regulating Hormones and Agents
Humans
Osteoporosis
Osteoporotic Fractures
Practice Guidelines as Topic
Risk Assessment
United States
English
This review, endorsed by the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, summarizes several failings of the recent guidelines of the American College of Physicians (ACP) on the treatment of low bone density or osteoporosis to prevent fractures.
INTRODUCTION
The ACP recently issued guidelines for the treatment of low bone density or osteoporosis to prevent fractures.
METHODS
Literature review and critical review of the ACP guidelines.
RESULTS
The guideline is lacking in scope due to the endorsement of treatment based on T-scores rather than fracture risk assessment and in failure to adequately consider anabolic therapies.
CONCLUSIONS
The ACP guideline appears outdated.
INTRODUCTION
The ACP recently issued guidelines for the treatment of low bone density or osteoporosis to prevent fractures.
METHODS
Literature review and critical review of the ACP guidelines.
RESULTS
The guideline is lacking in scope due to the endorsement of treatment based on T-scores rather than fracture risk assessment and in failure to adequately consider anabolic therapies.
CONCLUSIONS
The ACP guideline appears outdated.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1007/s00198-018-4504-y
- PMID 29869039
- Persistent URL
- https://folia.unifr.ch/global/documents/229682
Statistics
Document views: 9
File downloads:
- fulltext.pdf: 0